Company: SMNR
Filing Date: 2025-04-21
Form Type: S-4/A
Source: 0001193125-25-087342
Chunk: 567

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-04-21
Form: S-4/A
Chunk 567
---
 2024, and as of January 1, 2024 for the year ended December 31, 2024. As the Business Combination is being reflected as if it had occurred at the beginning of the period presented, the calculation of weighted average shares outstanding for basic and diluted net income (loss) per share assumes that the shares issuable relating to the Business Combination have been outstanding for the entire periods presented. If the maximum or an interim number of shares of Denali Class A Ordinary Shares are redeemed, this calculation is retroactively adjusted to eliminate such shares for the entire periods.As of December 31, 2024Pro FormaCombined(Assuming NoRedemptions)Pro FormaCombined(Assuming 25%Redemption)Pro FormaCombined(Assuming 50%Redemption)Pro FormaCombined(Assuming 75%Redemption)Pro FormaCombined(Assuming 100%Redemption)Pro forma net loss (in thousands)$(366,096)$(366,096)$(366,096)$(366,096)$(366,096)Weighted average shares outstanding – basic and diluted (thousands)(1)(2)211,620211,609211,598211,587211,576Net loss per share – basic and diluted$(1.73)$(1.73)$(1.73)$(1.73)$(1.73)(1)The no redemption scenario is comprised of 211,619,502 weighted average of shares of New Semnur Common Stock outstanding. The 25% redemption scenario is comprised of 211,608,567 weighted average shares of New Semnur Common Stock outstanding. The 50% redemption scenario is comprised of 211,597,632 weighted average shares of New Semnur Common Stock outstanding. The 75% redemption scenario is comprised of 211,586,697 weighted average of shares of New Semnur Common Stock outstanding. The 100% redemption scenario is comprised of 211,575,763 weighted average shares of New Semnur Common Stock outstanding.All scenarios under the diluted Earnings Per Share (“EPS”) calculation exclude the potential dilutive effect of the following securities because it is unknown whether such securities will ever be exercised for shares of New Semnur Common Stock: (a) 8,235,378 Public Warrants outstanding, (b) 14,622 Public Warrants underlying the Public Units, (c) 510,000 Denali Private Placement